These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3464022)

  • 21. The role of locomotion in lymphocyte migration.
    Freitas AA; Bognacki J
    Immunology; 1979 Feb; 36(2):247-55. PubMed ID: 220182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microtubule disruption enhances prostaglandin E2 production in osteoblastic cells.
    Yeh CK; Rodan GA
    Biochim Biophys Acta; 1987 Mar; 927(3):315-23. PubMed ID: 2880609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the immune response by prostaglandins.
    Goodwin JS; Ceuppens J
    J Clin Immunol; 1983 Oct; 3(4):295-315. PubMed ID: 6140268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandins enhance intercellular adhesion of Vero cells infected with herpes simplex virus.
    Harbour DA; Hill TJ; Blyth WA
    J Gen Virol; 1983 Mar; 64 Pt 3():507-12. PubMed ID: 6298342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocyte adherence in multiple sclerosis: lack of virus specificity.
    Dore-Duffy P; Zurier RB
    Cell Immunol; 1983 Apr; 77(2):215-21. PubMed ID: 6303601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
    Chouaib S; Welte K; Mertelsmann R; Dupont B
    J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin effect on lymphokine production in multiple sclerosis.
    Willoughby EW; Dupont B; Good RA
    Ann Neurol; 1979 Apr; 5(4):391-3. PubMed ID: 375809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocyte-endothelial cell interactions in multiple sclerosis: disease specificity and relationship to circulating tumour necrosis factor-alpha and soluble adhesion molecules.
    Vora AJ; Kidd D; Miller DH; Perkin GD; Hughes RA; Ellis BA; Dumonde DC; Brown KA
    Mult Scler; 1997 Jun; 3(3):171-9. PubMed ID: 9310962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related differences in lymphocyte adherence to myelinated tissue in multiple sclerosis.
    Dore-Duffy P; Longo M; Cohen K; Goertz V
    Neurology; 1987 Aug; 37(8):1402-5. PubMed ID: 3614669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of colchicine on PGE1 stimulation of cAMP1 formation in human lymphoblastoid and normal lymphocytes.
    Stolc V
    Exp Cell Biol; 1979; 47(6):401-8. PubMed ID: 230101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple sclerosis: the rational basis for treatment with colchicine and evening primrose oil.
    Horrobin DF
    Med Hypotheses; 1979 Mar; 5(3):365-78. PubMed ID: 313499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced effects of prostaglandin E1 and dibutyryl cyclic AMP upon human lymphocytes in the presence of cortisol.
    Mendelsohn J; Multer MM; Boone RF
    J Clin Invest; 1973 Sep; 52(9):2129-37. PubMed ID: 4353772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheumatoid synovial cell morphologic changes induced by a mononuclear cell factor in culture.
    Baker DG; Dayer JM; Roelke M; Schumacher HR; Krane SM
    Arthritis Rheum; 1983 Jan; 26(1):8-14. PubMed ID: 6297509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous and allogeneic mixed-lymphocyte responses following thermal injury in man: the immunomodulatory effects of interleukin 1, interleukin 2, and a prostaglandin inhibitor, WY-18251.
    Antonacci AC; Calvano SE; Reaves LE; Prajapati A; Bockman R; Welte K; Mertelsmann R; Gupta S; Good RA; Shires GT
    Clin Immunol Immunopathol; 1984 Feb; 30(2):304-20. PubMed ID: 6229378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.
    Makoul GT; Robinson DR; Bhalla AK; Glimcher LH
    J Immunol; 1985 Apr; 134(4):2645-50. PubMed ID: 2857750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of human peripheral blood monocyte collagenase by prostaglandins and anti-inflammatory drugs.
    Wahl LM; Lampel LL
    Cell Immunol; 1987 Apr; 105(2):411-22. PubMed ID: 3032463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,25-Dihydroxyvitamin D3 enhances prostaglandin E2 production by monocytes. A mechanism which partially accounts for the antiproliferative effect of 1,25(OH)2D3 on lymphocytes.
    Koren R; Ravid A; Rotem C; Shohami E; Liberman UA; Novogrodsky A
    FEBS Lett; 1986 Sep; 205(1):113-6. PubMed ID: 3462028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 1. Association between amount of prostaglandin produced, natural killer, and endogenous interferon.
    Merrill JE; Gerner RH; Myers LW; Ellison GW
    J Neuroimmunol; 1983 Jun; 4(3):223-37. PubMed ID: 6189855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin production in chronic progressive multiple sclerosis.
    Aberg JA; Demers LM; Romano PJ; Tenser RB
    J Clin Lab Anal; 1990; 4(4):246-50. PubMed ID: 2391581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of microtubule-disrupting agents on superoxide production in human polymorphonuclear leukocytes.
    Kitagawa S; Takaku F
    Biochim Biophys Acta; 1982 Dec; 719(3):589-98. PubMed ID: 6295508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.